Author:
Anastassakis Konstantinos
Publisher
Springer International Publishing
Reference118 articles.
1. Frye SV, Bramson HN, Hermann DJ, Lee FW, Sinhababu AK, Tian G. Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase. Pharm Biotechnol. 1998;11:393–422.
2. US Food Drug Administration Center for Drug Evaluation and Research. Application Number 21–319 Clinical pharmacology and biopharmaceutics review. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21319_Duagen_biopharmr_P1.pdf. Accessed 4 Mar 2013.
3. Tian G, Mook RA Jr, Moss ML, Frye SV. Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies. Biochemistry. 1995;34(41):13453–9.
4. Frye SV. Discovery and clinical development of Dutasteride, a potent dual 5alpha-reductase inhibitor. Curr Top Med Chem. 2006;6(5):405–21.
5. Foley CL, Kirby RS. 5 Alpha-reductase inhibitors: what’s new? Curr Opin Urol. 2003;13(1):31–7.